Bankole A. Johnson - Net Worth and Insider Trading

Bankole A. Johnson Net Worth

The estimated net worth of Bankole A. Johnson is at least $41,443 dollars as of 2024-05-21. Bankole A. Johnson is the Chief Medical Officer of Adial Pharmaceuticals Inc and owns about 28,979 shares of Adial Pharmaceuticals Inc (ADIL) stock worth over $41,443. Details can be seen in Bankole A. Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bankole A. Johnson has not made any transactions after 2021-04-06 and currently still holds the listed stock(s).

Transaction Summary of Bankole A. Johnson

To

Bankole A. Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bankole A. Johnson owns 1 companies in total, including Adial Pharmaceuticals Inc (ADIL) .

Click here to see the complete history of Bankole A. Johnson’s form 4 insider trades.

Insider Ownership Summary of Bankole A. Johnson

Ticker Comapny Transaction Date Type of Owner
ADIL Adial Pharmaceuticals Inc 2021-04-06 director & 10 percent owner

Bankole A. Johnson Latest Holdings Summary

Bankole A. Johnson currently owns a total of 1 stock. Bankole A. Johnson owns 28,979 shares of Adial Pharmaceuticals Inc (ADIL) as of April 6, 2021, with a value of $41,443.

Latest Holdings of Bankole A. Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADIL Adial Pharmaceuticals Inc 2021-04-06 28,979 1.43 41,443

Holding Weightings of Bankole A. Johnson


Bankole A. Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, Bankole A. Johnson has made a total of 3 transactions in Adial Pharmaceuticals Inc (ADIL) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Adial Pharmaceuticals Inc is the sale of 6,000 shares on April 6, 2021, which brought Bankole A. Johnson around $375,000.

Insider Trading History of Bankole A. Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bankole A. Johnson Trading Performance

GuruFocus tracks the stock performance after each of Bankole A. Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bankole A. Johnson is -51.02%. GuruFocus also compares Bankole A. Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bankole A. Johnson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bankole A. Johnson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bankole A. Johnson

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.66
Relative Return to S&P 500(%) -29.49

Bankole A. Johnson Ownership Network

Ownership Network List of Bankole A. Johnson

No Data

Ownership Network Relation of Bankole A. Johnson


Bankole A. Johnson Owned Company Details

What does Adial Pharmaceuticals Inc do?

Who are the key executives at Adial Pharmaceuticals Inc?

Bankole A. Johnson is the director & 10 percent owner of Adial Pharmaceuticals Inc. Other key executives at Adial Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Stilley William B. Iii , COO and CFO Joseph Truluck , and 10 percent owner En Fidecomiso De Mi Vida 11/23/2010 Trust .

Adial Pharmaceuticals Inc (ADIL) Insider Trades Summary

Over the past 18 months, Bankole A. Johnson made no insider transaction in Adial Pharmaceuticals Inc (ADIL). Other recent insider transactions involving Adial Pharmaceuticals Inc (ADIL) include a net purchase of 700 shares made by Kevin Schuyler ,

In summary, during the past 3 months, insiders sold 0 shares of Adial Pharmaceuticals Inc (ADIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adial Pharmaceuticals Inc (ADIL) were sold and 700 shares were bought by its insiders, resulting in a net purchase of 700 shares.

Adial Pharmaceuticals Inc (ADIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adial Pharmaceuticals Inc Insider Transactions

No Available Data

Bankole A. Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for Bankole A. Johnson. You might contact Bankole A. Johnson via mailing address: 1180 Seminole Trail, Suite 495, Charlottesville Va 22901.

Discussions on Bankole A. Johnson

No discussions yet.